Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
57.98199
male
1
33
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
41
461,451
null
null
39.75
asian
20.296875
55
0.743896
0.66394
4
0
0
no
0.1
0.5
dnr after sadm
31
75
12.898438
75
22
38
145
2.699707
3.599609
1.099854
132
7.619141
160
28
3,700
null
null
<2 mo. follow-up
2.932129
33
1
54.88599
male
0
10
CHF
COPD/CHF/Cirrhosis
3
14
under $11k
0
39,274
19,644.2188
19,136.5469
20
black
19.597656
19
0.891968
0.81897
1
1
0
no
0.8
0.8
no dnr
10
65
14.199219
65
16
35.59375
null
null
null
1.599854
125
null
null
35
3,550
0
0
no(M2 and SIP pres)
0
443
0
31.84099
female
0
9
Colon Cancer
Cancer
1
12
null
0
34,588
15,645.4297
19,370.5
12
white
18.199219
23
0.856934
0.681885
1
0
0
metastatic
1
0.9
no dnr
9
82
0.599976
115
12
39
null
null
0.599976
1.899902
136
null
261
46
2,915
0
null
null
0.494751
441
0
55.43298
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
35,245
16,080.6328
18,295.3281
18
white
20.296875
33
0.876953
0.832886
1
0
0
no
0.9
0.8
no dnr
9
0
24.199219
0
0
36.19531
274.25
1.199951
10.099609
2.799805
142
7.349609
null
92
14
null
6
SIP>=30
6
441
0
86.55396
male
0
10
Coma
Coma
1
7
under $11k
44
139,613
27,035.8438
28,399.7344
40
white
26.699219
39
0.130981
0.082993
6
0
0
no
null
null
no dnr
10
65
17.796875
104
32
36.79688
148.3125
null
null
1
144
7.489258
118
21
2,075
null
0
<2 mo. follow-up
0
37
1
36.89297
female
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
under $11k
44
556,242
116,165.5
84,961.5
21.75
black
25.199219
30
0.685913
0.592896
44
0
0
no
0.95
0.95
no dnr
54
83
2.5
80
22
35.79688
null
4.199219
0.799927
0.799927
133
null
null
3
3,000
null
5
null
5
64
1
68.51196
male
0
58
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
26
265,912
null
null
27.25
black
38.195313
61
0.28595
0.175995
4
0
0
no
0.7
0.6
no dnr
58
55
6.5
115
16
35.89844
null
null
null
1.799805
137
null
null
26
1,375
null
5
SIP>=30
5
240
1
34.23999
female
0
18
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
120,821
55,423.3438
49,301.0312
25.333328
white
18.199219
18
0.93689
0.892944
1
0
0
no
0.95
0.9
no dnr
18
58
10.599609
115
31
38.19531
162.5
3.899902
31
4.199219
135
7.489258
174
83
0
0
null
no(M2 and SIP pres)
0.494751
436
0
75.28296
female
0
50
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
542,002
152,701.875
146,630.375
39
white
33.898438
56
0.45697
0.337952
11
1
0
no
null
null
no dnr
50
55
8.699219
70
20
36.09375
null
3.399902
1
1.599854
135
null
null
38
2,425
null
null
null
2.881836
235
1
77.54999
female
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
9
382,453
145,990.75
140,280.125
43.5
white
29
62
0.53894
0.424988
10
0
0
no
0.2
0.2
no dnr
51
67
14.798828
74
22
36.19531
null
3.299805
3.899902
3.099609
136
null
85
80
590
null
null
null
2.792481
434
0
30.97899
male
0
39
Coma
Coma
0
12
null
61
229,100
103,634.5
90,354.6875
26.75
hispanic
22
35
0.746948
0.699951
1
0
0
no
0.75
0.75
no dnr
39
75
14.298828
120
44
39
157.125
2.199707
0.799927
1.699951
139
7.509766
438
32
2,635
null
0
no(M2 and SIP pres)
0
435
0
63.63898
female
1
55
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$11-$25k
26
902,281
191,182.375
179,734.125
37
hispanic
34.296875
65
0.360962
0.242981
39
0
0
no
0.1
0.1
dnr after sadm
46
57
23.898438
105
9
36.59375
256
null
38.398438
3.299805
138
7.439453
109
66
1,965
null
null
<2 mo. follow-up
3.065918
55
1
46.935
female
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
61
160,986
null
null
18.25
white
23.5
28
0.619995
0.515991
2
0
0
yes
0.95
0.9
no dnr
28
75
10.599609
60
14
36
null
null
null
0.699951
133
null
202
22
null
null
null
null
4.486328
432
0
45.27597
female
0
14
CHF
COPD/CHF/Cirrhosis
1
null
null
0
76,227
28,078.3281
27,865.7656
17.666656
black
33.5
73
0.75
0.605957
1
1
0
no
0.5
0.4
no dnr
14
75
11.298828
75
25
38.19531
215
2.299805
2.099609
1.699951
134
7.509766
null
30
1,651
null
null
<2 mo. follow-up
3.168945
46
1
39.86899
male
1
30
MOSF w/Malig
ARF/MOSF
1
null
null
26
497,787
114,284.062
106,068.875
34
white
45.398438
78
0.022999
0.004999
37
0
0
yes
0.05
0
dnr after sadm
29
62
6.5
115
24
36.5
null
null
null
0.799927
136
null
188
19
3,600
null
null
<2 mo. follow-up
2.560059
30
1
65.73596
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
37
195,264
97,759.1875
83,391
39.666657
white
32.5
63
0.477966
0.359985
1
0
0
no
0.7
0.6
no dnr
23
71
4.199219
120
24
38.39844
null
3.699707
2.399902
0.599976
139
null
138
6
3,350
null
null
no(M2 and SIP pres)
3.458008
430
0
49.34198
female
1
17
Coma
Coma
2
22
$25-$50k
44
201,340
37,985.2188
36,139.25
36.333313
hispanic
17
23
0.688965
0.633911
34
0
0
no
0.5
0.5
dnr after sadm
7
115
31.796875
95
16
36.79688
524
null
null
1.199951
155
6.959961
651
14
2,400
null
5
<2 mo. follow-up
5
17
1
59.35397
female
0
9
Colon Cancer
Cancer
1
18
null
0
30,984
14,547.3594
16,878.5781
14
white
14.298828
16
0.85791
0.684937
1
0
0
metastatic
1
0.9
no dnr
9
108
11
135
10
37
227.5
null
null
2.199707
153
7.509766
125
59
1,852
0
0
no(M2 and SIP pres)
0
218
1
73.52795
female
0
5
COPD
COPD/CHF/Cirrhosis
2
null
null
0
5,988
3,484.082
3,056.75
6
white
15.898438
6
0.868896
0.783936
1
0
0
no
0.9
0.8
no dnr
5
97
16.296875
140
28
36.59375
226.65625
null
null
0.599976
137
7.529297
null
3
2,416
null
null
null
2.569336
424
0
71.18695
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
20
>$50k
41
201,762
29,839.5781
28,500.9062
56.5
asian
50.695313
75
0.007
0.001
9
1
0
no
0.4
0.1
dnr after sadm
6
52
4.899414
60
24
33.39844
null
null
null
4.199219
144
null
117
43
759
null
1
<2 mo. follow-up
1
7
1
60.22198
male
0
16
CHF
COPD/CHF/Cirrhosis
3
null
null
0
53,341
26,078.8125
28,201.2969
26
black
20.699219
33
0.86792
0.780884
1
1
0
no
0.8
0.5
no dnr
16
65
11.5
70
24
35.89844
null
null
null
0.899902
134
null
104
18
2,675
null
null
<2 mo. follow-up
3.364258
19
1
75.29895
male
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
9
361,878
102,817.562
90,455.375
32.5
white
33.898438
72
0.297974
0.186981
24
0
0
yes
0.5
0.45
no dnr
54
60
15.298828
110
10
36.5
112
null
null
5.199219
136
7.519531
165
130
1,136
null
0
adl>=4 (>=5 if sur)
0
239
1
66.53497
male
0
7
CHF
COPD/CHF/Cirrhosis
1
null
null
0
22,157
10,879.25
9,364.84375
17.5
asian
22.597656
33
0.826904
0.717896
1
0
0
no
0.6
0.5
no dnr
7
62
31.199219
155
22
38.29688
93.84375
1.599854
0.299988
0.699951
135
7.389648
175
21
4,280
null
null
null
2.81543
172
1
20.29599
female
1
40
MOSF w/Malig
ARF/MOSF
2
12
null
0
355,578
null
null
35.25
hispanic
47.398438
67
0.07399
0.026997
2
0
0
metastatic
0.9
0.9
no dnr
40
122
21.199219
155
10
38
null
3.799805
0.5
1.199951
143
null
122
8
2,397
null
1
<2 mo. follow-up
1
40
1
68.82098
female
0
7
COPD
COPD/CHF/Cirrhosis
5
12
under $11k
0
21,750
11,069.8047
9,266.08594
13.5
white
26.898438
52
0.746948
0.600952
1
1
0
no
0.8
0.5
no dnr
7
113
38.59375
105
9
38
342.5
4.099609
15.398438
4.399414
133
7.449219
123
170
0
4
6
null
6
419
0
60.29797
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
51,183
23,294.4844
26,903.875
22
white
26.097656
56
0.792969
0.724976
1
0
0
no
null
null
no dnr
11
82
13.798828
120
32
39.59375
590
3.799805
null
0.799927
136
7.469727
null
8
2,735
null
null
null
2.783691
415
0
87.35394
female
0
4
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
9
11,602
5,440.957
5,021.9375
9
white
17.5
27
0.797974
0.67395
1
0
1
no
0.95
0.85
dnr after sadm
1
47
20.5
154
38
35.59375
138.75
null
0.799927
7.699219
152
7.429688
224
125
0
null
null
no(M2 and SIP pres)
5.25
210
1
58.32999
female
0
13
MOSF w/Malig
ARF/MOSF
1
8
under $11k
9
57,209
19,964.7031
19,905.25
14.5
white
27.699219
57
0.425964
0.306946
6
0
0
metastatic
0.7
0.5
dnr after sadm
1
113
14.298828
150
30
36.39844
161.21875
3.799805
0.599976
6.199219
130
7.40918
408
62
0
null
6
adl>=4 (>=5 if sur)
6
147
1
79.12897
female
0
9
COPD
COPD/CHF/Cirrhosis
3
13
under $11k
0
25,770
11,566.8984
8,506.60938
12.5
white
17.296875
31
0.826904
0.717896
1
0
0
no
0.9
0.5
no dnr
9
52
0.049995
115
14
37.5
226.0625
null
18.5
2.099609
134
7.399414
111
58
3,149
2
null
<2 mo. follow-up
1.838867
59
1
41.09799
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
$25-$50k
0
43,026
18,923.1094
19,165.8281
20.5
hispanic
29.597656
47
0.794922
0.727905
2
0
0
no
0.9
0.9
no dnr
8
57
13.398438
140
10
36.39844
230
3.099609
2
2.899902
151
7.439453
153
108
2,420
0
0
null
0
411
0
72.13995
male
1
7
Lung Cancer
Cancer
3
12
$11-$25k
0
30,670
13,482.5156
12,862
26.5
black
22.699219
39
0.556885
0.234985
1
1
0
metastatic
0.3
0.1
dnr after sadm
2
130
8.199219
110
6
37.5
370
2.599609
0.899902
0.899902
144
7.579102
333
8
3,020
null
1
<2 mo. follow-up
1
7
1
40.74698
male
0
64
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
null
26
310,749
128,527.625
111,230.562
31
white
48.59375
83
0.211975
0.116989
2
0
0
no
0.5
0.4
no dnr
64
69
7.5
74
16
36.39844
null
null
0.599976
1.099854
135
null
78
12
1,525
null
0
adl>=4 (>=5 if sur)
0
408
0
66.67798
male
1
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
192,030
43,920.3438
38,370.5312
24.666656
hispanic
16.097656
16
0.804932
0.73999
41
0
0
yes
0.5
0.1
dnr after sadm
18
89
8
86
22
36.79688
392
null
null
0.899902
132
7.399414
null
13
null
null
1
<2 mo. follow-up
1
18
1
32.008
male
1
43
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
44
348,165
null
null
25.25
hispanic
24.699219
36
0.724976
0.640991
25
0
0
no
0.5
0.3
dnr after sadm
5
52
18.5
135
16
38.09375
98.5625
2.899902
33.5
2.699707
144
7.489258
249
76
3,850
null
null
<2 mo. follow-up
3.895996
43
1
62.32397
female
1
66
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
41
916,502
null
null
41
white
35.5
64
0.261963
0.155975
27
0
0
no
0.9
0.8
dnr after sadm
64
65
11.699219
80
24
35.89844
null
null
1.299805
2
137
null
147
79
4,330
null
3
adl>=4 (>=5 if sur)
3
66
1
54.96799
male
0
43
MOSF w/Malig
ARF/MOSF
1
14
null
26
347,848
94,807.5
85,532.375
30.5
white
24.398438
46
0.401978
0.282959
18
0
0
metastatic
0.55
0.5
no dnr
43
70
36.296875
170
47
37.59375
124.48438
null
null
1.799805
149
7.469727
279
43
1,494
null
1
SIP>=30
1
403
0
40.82098
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
26
58,518
25,931.4062
29,012.9062
36.5
white
23.597656
48
0.828979
0.770996
1
1
0
no
0.5
0.5
no dnr
12
62
5.799805
105
16
36
null
null
null
1.799805
133
null
202
71
2,120
null
0
no(M2 and SIP pres)
0
403
0
69.48096
female
0
11
Colon Cancer
Cancer
1
11
under $11k
0
30,978
13,760.3516
15,334.9453
15
hispanic
4.799805
15
0.92395
0.821899
1
0
0
metastatic
1
0.9
no dnr
11
32
0.049995
155
22
39
null
null
1.199951
1.099854
133
null
null
10
7,750
null
0
null
0
399
0
58.793
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
234,692
24,678.2344
22,899.5312
48
white
67.796875
111
0
0
42
0
0
yes
0.5
0.5
dnr after sadm
4
111
10.199219
104
34
36
122.5
null
null
0.899902
138
7.30957
null
22
49
null
null
<2 mo. follow-up
1.963379
5
1
52.22699
female
0
22
Coma
Coma
1
7
null
44
192,402
48,440.875
48,410.0625
24.666656
white
22.199219
27
0.576904
0.510986
8
0
0
no
null
null
no dnr
22
72
6.599609
115
12
38.29688
547.5
null
null
4.099609
143
7.119141
395
50
2,535
null
null
no(M2 and SIP pres)
2.266602
398
0
94.54895
female
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
55
88,695
36,447.625
38,428.4062
32
black
33
37
0.177979
0.090988
1
0
0
no
0.15
0.05
dnr after sadm
7
107
13.798828
64
24
36.79688
195.21875
3.599609
null
0.899902
140
7.349609
175
13
1,500
null
6
<2 mo. follow-up
6
13
1
49.70599
male
0
73
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
$11-$25k
26
910,119
177,845.75
149,915.625
45.75
hispanic
34.5
59
0.454956
0.335999
32
0
0
no
0.3
0.3
no dnr
73
132
15.798828
110
46
36.79688
190.46875
null
null
1.899902
142
7.509766
114
38
2,200
null
0
no(M2 and SIP pres)
0
396
0
77.06494
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
26
26,899
11,858.2734
11,839.2891
18.5
white
16.5
25
0.807983
0.743896
1
0
1
no
null
null
dnr after sadm
1
137
5.899414
65
24
36
247.59375
null
null
0.799927
135
7.469727
92
19
2,200
null
null
null
5.412109
66
1
65.95996
male
1
8
MOSF w/Malig
ARF/MOSF
3
12
under $11k
100
68,139
26,086.8594
30,802.7656
35
white
33.09375
60
0.042
0.011999
1
0
0
yes
0.2
0.5
no dnr
8
62
17.5
55
0
36.19531
206.65625
null
1.299805
2.399902
142
7.40918
139
39
5,210
null
6
<2 mo. follow-up
6
8
1
42.82797
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
20
>$50k
26
85,800
32,954.5312
36,539.3125
33
white
31.398438
55
0.691895
0.599976
1
0
0
no
0.5
0.5
no dnr
14
78
7.799805
125
28
36.09375
null
null
0.399963
1.399902
135
null
199
46
1,687
null
0
no(M2 and SIP pres)
0
394
0
86.71594
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
0
25,502
11,281.9609
9,619.875
14
white
17.398438
20
0.826904
0.767944
1
0
0
no
0.95
0.85
no dnr
11
35
13
120
26
38.5
128
3.899902
2.099609
7.899414
138
7.429688
119
88
0
0
0
no(M2 and SIP pres)
0
394
0
68.07397
male
0
9
COPD
COPD/CHF/Cirrhosis
1
8
$11-$25k
0
66,904
19,334.0625
17,372.3594
27
white
29.296875
24
0.585938
0.393982
5
0
0
yes
0.5
0.2
no dnr
9
73
6.299805
75
22
36.5
260
null
1.099854
1
134
7.5
null
6
2,622
5
6
<2 mo. follow-up
6
43
1
50.56299
male
0
31
Coma
Coma
1
16
>$50k
44
232,891
96,200.25
90,288.8125
39
white
19
15
0.690918
0.635986
4
0
0
no
0.5
0.5
no dnr
31
102
20.898438
125
54
38.59375
435
null
null
1.099854
145
7.25
100
13
5,400
null
null
null
2.170898
391
0
60.54498
male
1
31
MOSF w/Malig
ARF/MOSF
1
16
>$50k
26
239,928
76,509.625
71,946
26.5
white
25.5
41
0.444946
0.325989
19
0
0
yes
0.2
0.15
dnr after sadm
12
108
22
125
35
36.39844
null
null
11.398438
2.099609
146
7.519531
220
73
3,100
null
4
<2 mo. follow-up
4
31
1
45.81497
female
0
168
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
>$50k
44
1,161,504
null
null
40.25
hispanic
40.195313
86
0.356995
0.238983
1
0
0
no
0.3
0.15
no dnr
168
67
5.699219
145
36
39.59375
291.8125
null
null
1.199951
135
7.5
108
20
1,561
null
0
no(M2 and SIP pres)
0
391
0
81.57397
male
0
9
CHF
COPD/CHF/Cirrhosis
2
16
$25-$50k
0
19,878
11,246.7969
9,558.08594
12.5
white
16.199219
17
0.817993
0.704956
1
0
0
yes
0.9
0.75
no dnr
9
62
6.5
115
27
38.5
192
null
null
1.099854
131
7.369141
502
20
4,590
2
null
adl>=4 (>=5 if sur)
1.838867
64
1
83.35895
female
1
5
Coma
Coma
2
null
$25-$50k
44
22,522
9,069.2344
9,840.16406
27
white
18
32
0.480957
0.408997
1
1
0
no
0.15
0.1
dnr after sadm
2
107
6.199219
100
20
38.19531
null
4.299805
0.399963
1
140
null
102
14
1,445
null
7
<2 mo. follow-up
7
5
1
79.65796
male
0
5
Lung Cancer
Cancer
1
11
under $11k
0
10,991
5,674.75
6,170.38672
10
black
12.798828
23
0.75293
0.495972
1
0
0
metastatic
0.8
0.4
dnr after sadm
1
38
1
145
40
39.19531
78.75
null
10
2.699707
130
7.5
117
81
1,315
6
5
adl>=4 (>=5 if sur)
5
84
1
18.502
female
0
44
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
37
327,791
124,510.062
121,448.562
37.25
hispanic
28.398438
43
0.785889
0.715942
3
0
0
no
0.6
0.6
no dnr
44
115
15.099609
125
20
38.5
null
5.699219
null
0.699951
149
null
151
20
3,865
null
null
SIP>=30
2.486328
386
0
62.52197
male
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
$11-$25k
41
279,274
61,933.125
60,556.7812
56.5
hispanic
28.097656
51
0.412964
0.293945
12
0
0
yes
0.15
0.05
dnr after sadm
11
48
15.298828
105
6
36.19531
303.3125
3.299805
1.099854
2.5
142
7.399414
169
43
2,025
null
7
<2 mo. follow-up
7
13
1
66.15198
male
0
22
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
80,163
36,860.3125
31,019.375
22
black
32.296875
52
0.638916
0.457947
2
1
0
no
0.95
0.85
no dnr
22
115
2.299805
125
28
38.79688
356
null
17.597656
1.099854
136
7.379883
243
34
5,026
5
4
adl>=4 (>=5 if sur)
4
384
0
86.37097
male
0
4
CHF
COPD/CHF/Cirrhosis
3
null
under $11k
9
9,019
5,309.8047
4,714.75781
20
white
20.199219
31
0.757935
0.616943
1
0
1
no
0.9
0.75
dnr after sadm
2
70
7.5
65
20
36
266.625
null
null
0.799927
143
7.5
322
16
1,350
null
null
null
5.987305
383
0
59.31
female
0
11
MOSF w/Malig
ARF/MOSF
1
14
>$50k
0
63,881
27,277.3281
23,431.3594
29.5
white
32.898438
55
0.487976
0.369995
1
0
0
yes
0.9
0.7
no dnr
11
62
2.299805
105
31
39.29688
162
2.199707
2.299805
1.599854
151
7.549805
148
78
2,126
5
5
SIP>=30
5
242
1
68.34198
male
1
24
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
26
null
null
null
33.666657
white
25.796875
29
0.596924
0.406982
12
0
0
no
0.75
0.75
null
null
58
15.199219
90
12
36.29688
null
null
8
5.799805
145
null
null
130
2,145
null
1
<2 mo. follow-up
1
24
1
26.14099
male
1
8
MOSF w/Malig
ARF/MOSF
3
14
under $11k
44
87,952
30,212.125
30,602.7188
44.5
hispanic
30.796875
59
0.337952
0.221985
3
0
0
yes
0.85
0.85
dnr after sadm
7
75
23.5
76
20
37
242.84375
null
null
1.099854
132
7.439453
136
24
4,200
null
0
<2 mo. follow-up
0
8
1
51.26099
male
0
49
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
41
230,224
96,777.375
90,802.4375
30.5
white
39.09375
39
0.302979
0.190979
4
0
1
no
0.8
0.4
dnr before sadm
0
102
17.296875
95
20
36
116.3125
3.199707
1.399902
1.5
136
7.419922
180
39
2,295
null
null
null
5.682617
205
1
67.09399
female
0
68
COPD
COPD/CHF/Cirrhosis
2
14
under $11k
0
433,012
163,304.625
166,759.125
36.25
white
20.796875
21
0.794922
0.670898
2
0
0
yes
1
1
no dnr
68
125
14.398438
55
8
38.89844
322.5
null
null
0.699951
134
7.469727
315
15
2,055
null
4
null
4
381
0
60.26599
female
0
5
CHF
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
13,646
7,869.8555
6,478.39844
19
black
15
8
0.914917
0.855957
1
0
0
no
0.75
0.6
no dnr
5
65
15
125
40
38.89844
262.8125
null
null
0.799927
152
7.519531
244
30
2,795
0
null
null
0.494751
380
0
72.375
female
0
11
COPD
COPD/CHF/Cirrhosis
4
18
>$50k
26
53,913
20,428.3906
17,345.5938
20
white
36.796875
44
0.294983
0.118988
3
0
0
no
0.65
0.65
no dnr
11
46
30.796875
170
48
36.39844
255
null
0.899902
5.099609
140
7.359375
158
89
349
null
null
null
5.023438
309
1
47.60599
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
26
174,923
31,521.7031
31,668.875
19.333328
white
23.796875
34
0.68396
0.590942
13
0
0
yes
0.85
0.7
no dnr
20
83
6.299805
100
22
38
null
null
null
1.5
138
null
null
22
2,850
null
0
null
0
365
0
65.25397
female
0
17
Coma
Coma
1
18
$25-$50k
44
149,859
38,738.5938
41,645.5938
32.666657
white
21
26
0.506958
0.435974
5
0
0
no
0.55
0.5
no dnr
17
58
14.798828
75
38
37.89844
526.5
null
null
0.799927
141
7.389648
144
11
1,150
null
0
adl>=4 (>=5 if sur)
0
142
1
54.103
male
0
52
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
467,237
167,344.375
164,658.375
51.75
white
41.796875
80
0.478943
0.359985
1
0
0
no
0.05
0.05
no dnr
52
63
6.599609
78
20
37.89844
null
null
null
1.299805
138
null
152
21
1,500
null
0
null
0
227
1
65.71698
female
1
41
ARF/MOSF w/Sepsis
ARF/MOSF
3
18
>$50k
37
460,259
173,739.375
184,564.75
49
asian
21.097656
31
0.746948
0.666992
1
0
0
no
0.7
0.7
no dnr
41
65
14.199219
140
15
39.5
182.21875
1.799805
3
0.5
141
7.389648
236
8
3,835
null
1
<2 mo. follow-up
1
41
1
83.06598
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
null
9
118,843
29,307.4219
28,632.1875
22.666656
black
18.699219
26
0.603882
0.497986
16
0
0
metastatic
0.5
0.15
no dnr
17
72
3
70
31
38.09375
135
null
2.799805
0.899902
148
7.539062
398
41
4,700
null
1
null
1
362
0
85.45099
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
20
null
94
65,216
null
null
33.5
white
38.09375
60
0.007
0.001
1
0
0
yes
0.3
0.3
no dnr
7
78
10.898438
125
22
38.19531
122.4375
null
0.299988
4.899414
133
7.319336
373
117
1,475
null
null
<2 mo. follow-up
4.566406
7
1
74.37396
male
0
10
CHF
COPD/CHF/Cirrhosis
4
6
$11-$25k
0
23,855
null
null
11.5
white
14.199219
19
0.891968
0.81897
1
0
0
no
0.8
0.5
no dnr
10
75
9.298828
64
12
36.59375
null
3.399902
1.199951
1.599854
134
null
97
24
2,950
0
0
no(M2 and SIP pres)
0
360
0
67.81696
male
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
5
null
under $11k
55
56,904
22,632.4375
20,936.9688
30.5
white
32.398438
70
0.257996
0.152985
2
1
0
yes
0.1
0
dnr after sadm
2
113
0.049995
130
11
39.09375
null
1.899902
null
0.5
135
null
114
15
4,684
null
7
<2 mo. follow-up
7
13
1
76.099
female
0
9
COPD
COPD/CHF/Cirrhosis
4
19
$11-$25k
9
53,633
15,800.9922
15,465.1797
16.5
white
30.296875
54
0.319946
0.136993
6
0
0
metastatic
0.6
0.5
no dnr
9
75
15.798828
115
10
36.39844
222.5
null
4.199219
0.799927
133
7.419922
null
20
2,420
0
0
no(M2 and SIP pres)
0
356
0
63.978
female
0
11
Colon Cancer
Cancer
1
13
$11-$25k
0
21,967
11,803.8203
11,124.2969
13.5
white
19.699219
19
0.779907
0.539917
1
0
0
metastatic
0.8
0.5
no dnr
11
73
0.599976
70
14
39.09375
153.03125
null
3.199707
1.599854
141
7.399414
null
30
3,295
1
null
null
1.166748
185
1
80.50397
male
1
4
Coma
Coma
2
null
null
55
23,637
9,525.2812
10,073.8672
23
white
21.597656
20
0.346985
0.274963
1
1
1
no
0.9
0.9
dnr before sadm
-1
48
10.898438
55
10
36.19531
41
null
null
0.899902
134
7.549805
109
20
2,460
null
null
<2 mo. follow-up
4.599609
4
1
60.69299
male
0
3
CHF
COPD/CHF/Cirrhosis
2
15
null
0
8,561
3,575.4902
3,659.09961
28
white
16
19
0.906982
0.842896
1
0
0
no
0.9
0.8
no dnr
3
72
21.296875
115
24
38.19531
272
null
null
0.699951
135
7.30957
173
7
2,180
0
0
no(M2 and SIP pres)
0
355
0
72.01898
male
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
26
136,226
57,056.75
54,969.0625
36.333313
white
36.796875
41
0.337952
0.221985
2
0
0
no
0.85
0.8
no dnr
24
78
5.299805
80
20
36
null
null
null
1.099854
139
null
110
16
3,800
null
0
<2 mo. follow-up
0
58
1
54.73798
male
0
17
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
156,205
84,656
68,870.875
34.333313
white
32
31
0.72998
0.576904
1
0
0
no
0.6
0.5
no dnr
17
62
13.199219
115
35
37.89844
103.32812
null
null
0.399963
126
7.319336
null
2
1,000
0
1
no(M2 and SIP pres)
1
352
0
45.85898
female
0
34
Coma
Coma
0
12
null
44
502,025
102,793.438
94,954.875
31.5
white
31.5
34
0.335999
0.263977
31
0
0
no
0.5
0.4
no dnr
34
106
17.597656
105
26
36.89844
301
null
null
0.399963
143
7.619141
209
28
1,590
null
0
adl>=4 (>=5 if sur)
0
352
0
63.53998
male
1
24
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$25-$50k
44
647,638
142,198.625
129,240.75
51
hispanic
45
83
0.044998
0.014
27
0
0
no
0.05
0.02
dnr after sadm
21
120
10.298828
120
25
37.79688
210
null
null
1.199951
142
7.5
null
15
3,445
null
0
<2 mo. follow-up
0
24
1
84.70599
female
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
19
>$50k
44
26,000
11,751.9062
11,874.8828
17
white
25.296875
51
0.434998
0.314941
1
0
1
yes
0.7
0.4
dnr after sadm
2
67
15.898438
175
14
39.19531
135.6875
4.199219
9.599609
2.799805
156
7.459961
196
83
6,910
null
null
<2 mo. follow-up
5.836914
6
1
63.017
male
0
9
Lung Cancer
Cancer
1
27
>$50k
0
26,494
13,606.3359
14,991.0469
13
white
17.398438
8
0.704956
0.419983
1
0
0
metastatic
1
0.6
no dnr
9
132
21.296875
105
24
38
288.5625
2.299805
1
0.799927
130
7.439453
null
24
6,603
0
null
<2 mo. follow-up
0.494751
31
1
30.741
female
0
56
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
89
364,515
188,889.25
159,707.125
34.75
black
34.09375
62
0.407959
0.28894
1
0
0
no
0.6
0.4
no dnr
56
68
12.699219
95
29
36.79688
250
null
null
1
137
7.5
147
22
2,028
null
0
no(M2 and SIP pres)
0
346
0
29.10899
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
26
44,220
16,745.4844
17,332.9219
24
white
25.796875
32
0.822998
0.763916
2
0
0
no
0.75
0.7
no dnr
8
60
19.296875
135
20
37
70
2.599609
null
2.5
131
7.239258
92
80
1,109
null
null
<2 mo. follow-up
3.044922
29
1
59.31
male
0
5
Colon Cancer
Cancer
1
15
>$50k
0
null
null
null
11
white
13.699219
11
0.86499
0.697998
1
0
0
metastatic
1
0.95
null
null
69
8.5
105
24
36
null
4.199219
0.799927
1.199951
142
null
117
18
1,810
null
null
no(M2 and SIP pres)
1.873047
346
0
49.76898
female
1
86
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
37
null
null
null
47
white
25.699219
46
0.650879
0.550903
15
0
0
no
0.5
0.5
dnr after sadm
46
45
7.899414
125
28
37.79688
322.8125
2.599609
null
8.199219
143
7.40918
293
58
0
null
null
adl>=4 (>=5 if sur)
3.320313
86
1
47.978
male
0
6
CHF
COPD/CHF/Cirrhosis
2
null
null
0
23,716
9,634.25
9,722.29688
34
white
27.199219
47
0.832886
0.726929
1
0
0
no
0.9
0.8
no dnr
6
122
9.5
120
30
38
75.5
null
null
0.899902
132
7.519531
null
19
2,560
null
null
null
2.381836
345
0
65.17999
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
4
14
>$50k
100
218,454
27,713.5
30,207.5469
55
white
44.59375
81
0.002
0
11
1
0
no
0.1
0.1
dnr after sadm
4
73
10
136
20
38.59375
null
null
0.099991
0.699951
135
null
null
13
4,500
null
1
<2 mo. follow-up
1
5
1
69.92694
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
3
13
under $11k
44
94,568
38,181.5312
41,316.8125
32
white
29.398438
57
0.417969
0.29895
1
0
0
yes
0.6
0.4
no dnr
20
83
17.898438
95
24
38.29688
150
null
0.699951
1.299805
149
7.5
431
37
3,850
null
null
SIP>=30
3.505859
308
1
66.57599
male
1
5
Colon Cancer
Cancer
1
12
$25-$50k
0
4,971
3,593.7559
null
12
white
48.898438
66
0.063995
0.001
1
0
0
metastatic
null
null
dnr after sadm
1
64
13.898438
64
24
36.79688
81.65625
2.799805
20.398438
2.399902
131
7.449219
null
null
null
null
0
<2 mo. follow-up
0
5
1
42.23999
male
1
4
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
0
16,101
9,690.9844
null
17
white
49.695313
68
0.125977
0.026997
12
0
0
no
0.9
0.8
dnr after sadm
4
67
15
92
20
34.69531
null
2.399902
30.597656
4.599609
117
null
null
null
null
0
0
<2 mo. follow-up
0
4
1
61.13599
male
0
8
Colon Cancer
Cancer
1
12
null
0
7,688
2,069.8438
null
7.5
white
22.398438
26
0.740967
0.475952
1
0
0
metastatic
0.1
0.001
dnr after sadm
1
90
10.398438
90
25
37
null
2.599609
0.799927
1.799805
139
null
null
null
null
2
1
<2 mo. follow-up
1
14
1
71.18994
male
0
4
COPD
COPD/CHF/Cirrhosis
3
8
under $11k
0
3,214
2,426.2617
null
11
black
19.5
26
0.80188
0.680908
1
0
0
yes
0.99
0.98
no dnr
4
107
15.298828
78
28
36.29688
400
null
null
1.599854
142
7.449219
null
null
null
null
null
SIP>=30
2.578125
211
1
59.59799
male
0
7
Lung Cancer
Cancer
2
15
null
0
7,063
5,217
null
11
white
28.398438
17
0.438965
0.129974
1
0
0
metastatic
0.9
0.5
no dnr
7
82
18
92
32
38
308
3.099609
0.899902
0.799927
124
7.479492
null
null
null
null
null
<2 mo. follow-up
3.402832
37
1
65.81
male
0
8
CHF
COPD/CHF/Cirrhosis
1
15
null
0
7,104
5,181.7969
null
9.5
black
12.099609
26
0.922974
0.869995
1
0
0
no
1
1
no dnr
8
113
5.399414
100
20
37.59375
380.9375
4.5
null
1.799805
143
7.479492
null
null
null
0
0
no(M2 and SIP pres)
0
2,029
0
67.88495
female
0
8
CHF
COPD/CHF/Cirrhosis
3
7
under $11k
0
7,143
5,452.7578
null
8
white
25.296875
48
0.782959
0.652954
1
0
0
no
0.95
0.75
dnr after sadm
1
60
11.199219
64
25
36
252
4
0.599976
5.399414
129
7.5
null
null
null
1
null
null
1.1669
2,028
0
42.70499
male
0
5
Lung Cancer
Cancer
1
14
$11-$25k
0
6,662
4,805.4062
null
20
white
24.597656
11
0.5979
0.278992
1
0
0
metastatic
null
0.3
no dnr
5
73
7.5
72
24
36.19531
null
2.699707
0.199982
0.699951
136
null
null
null
null
5
6
<2 mo. follow-up
6
17
1
79.35095
male
0
10
CHF
COPD/CHF/Cirrhosis
4
7
under $11k
0
10,774
8,725.1875
null
8
white
21.199219
28
0.750977
0.606934
1
1
0
yes
0.8
0.5
no dnr
10
101
10.699219
74
16
36.09375
155.09375
4.299805
null
1.899902
131
7.359375
null
null
null
2
1
<2 mo. follow-up
1
31
1
34.14398
female
1
16
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
100
44,464
19,419.25
null
43.333313
white
42.898438
71
0.100998
0.042
1
0
0
no
0.83
0.83
dnr after sadm
13
45
17.097656
158
40
37.5
121.65625
2.799805
3.5
1.399902
145
7.539062
null
null
null
null
null
<2 mo. follow-up
4.136719
16
1
85.12799
female
0
8
COPD
COPD/CHF/Cirrhosis
1
10
under $11k
0
11,331
6,966.8047
null
12.5
hispanic
20.398438
41
0.708984
0.54895
3
0
0
no
0.9
0.8
no dnr
8
76
7.099609
102
24
36.59375
209.5
3.099609
0.399963
0.899902
134
7.5
null
null
null
2
null
null
1.839
101
1